TARRYTOWN, N.Y. — Prestige Consumer Healthcare announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Co. for $230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of ~$30 million and expected annual EBITDA
LAKE FOREST, Ill. — Akorn, a leading specialty pharmaceutical company, Monday announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for betamethasone dipropionate lotion USP (Augmented), 0.05%. The product is manufactured at Akorn’s Amityville, N.Y. manufacturing facility.According to IQVIA, U.S. sales of betamethasone dipropionate
LAKE ZURICH, Ill., and LAKE FOREST, Ill. — Global health care company Fresenius Kabi plans to acquire U.S. prescription and over-the-counter drug maker Akorn for $4.3 billion. Under the deal, announced late Monday, Fresenius Kabi agreed to buy Akorn $34 per share, plus the assume about $450 million of debt. The U.S. headquarters for Akorn
LAKE FOREST, Ill. — Akorn Inc. has announced four appointments to its management team, including a new sales and marketing leader. The specialty generic pharmaceutical company said Monday that Jonathan Kafer has been hired as executive vice president of sales and marketing, a newly created position. In the role, he will oversee all commercial functions for Akorn’s business units, as well as play an
